Loading...
AnteoTech Limited
ADO.AX•ASX
Healthcare
Biotechnology
A$0.02
A$0.001(5.88%)
AnteoTech Limited (ADO.AX) Financial Performance & Income Statement Overview
Review AnteoTech Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
25.89%
↑ 25.89%
Operating Income Growth
4.38%
↑ 4.38%
Net Income Growth
29.82%
↑ 29.82%
Operating Cash Flow Growth
19.33%
↑ 19.33%
Operating Margin
2114.10%
↑ 2114.10%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
1599.22%
↑ 1599.22%
ROE
-134.10%
↓ 134.10%
ROIC
-114.51%
↓ 114.51%
AnteoTech Limited (ADO.AX) Income Statement & Financial Overview
Review AnteoTech Limited's (ADO.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $3.15M | -$3.70M | $379139.00 | $77941.00 |
| Cost of Revenue | $0.00 | $0.00 | $33139.00 | $0.00 |
| Gross Profit | $3.15M | -$3.70M | $346000.00 | $77941.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $0.91 | $1.00 |
| R&D Expenses | $1.97M | $4.16M | $2.11M | $960291.00 |
| SG&A Expenses | $2.85M | $2.00M | $3.92M | $5.10M |
| Operating Expenses | $4.82M | $6.16M | $6.02M | $6.06M |
| Total Costs & Expenses | $4.82M | $6.16M | $6.54M | $6.63M |
| Interest Income | $0.00 | $25004.00 | $29490.00 | $14059.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $231394.00 | $520524.00 | $519177.00 | $572351.00 |
| EBITDA | -$2.00M | -$6.006M | -$5.61M | -$8.54M |
| EBITDA Ratio | -$0.63 | $1.62 | -$14.79 | -$76.74 |
| Operating Income | -$1.67M | -$9.86M | -$6.16M | -$6.55M |
| Operating Income Ratio | -$0.53 | $2.67 | -$16.26 | -$84.08 |
| Other Income/Expenses (Net) | -$2.98M | $3.34M | $36990.00 | $98887.00 |
| Income Before Tax | -$4.64M | -$6.53M | -$6.13M | -$9.11M |
| Income Before Tax Ratio | -$1.47 | $1.76 | -$16.16 | -$116.87 |
| Income Tax Expense | -$2.45M | $0.00 | -$3.77M | -$1.00 |
| Net Income | -$2.19M | -$6.53M | -$2.35M | -$9.11M |
| Net Income Ratio | -$0.70 | $1.76 | -$6.21 | -$116.87 |
| EPS | -$0.001 | -$0.003 | -$0.001 | -$0.004 |
| Diluted EPS | -$0.001 | -$0.003 | -$0.001 | -$0.004 |
| Weighted Avg Shares Outstanding | $2.44B | $2.31B | $2.14B | $2.009B |
| Weighted Avg Shares Outstanding (Diluted) | $2.44B | $2.34B | $2.14B | $2.009B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan